Navigation Links
VetCentric Partners with Dechra Veterinary Products
Date:2/13/2009

Home delivery of Dechra's full product line, including VETORYL(R) Capsules, now available

GLEN BURNIE, Md., Feb. 13 /PRNewswire/ -- VetCentric, Inc., the nation's largest practice-to-home delivery provider of prescription medications and veterinary therapeutic diets, today announced an affiliation with Dechra Veterinary Products. VetCentric's prescription management service enables Dechra to expand its reach to veterinarians and pet owners by utilizing VetCentric's unique veterinary-supportive business model.

The agreement provides VetCentric's partner clinics with access to the entire Dechra otic, dermatological and ophthalmic product line, including VETORYL(R) Capsules, the newly FDA approved drug for the treatment of Cushing's Disease in dogs. This cutting edge medication provides veterinarians with a powerful new tool to treat a very difficult disease. Veterinarians now have the ability to prescribe this innovative treatment directly through VetCentric, providing convenient home delivery for their clients and increasing compliance which results in better control of this disease.

"Our relationship with Dechra is an important step in our pursuit of offering the highest quality and most comprehensive selection of veterinary products to the practices and clients we serve. This announcement further solidifies VetCentric's position in the industry as the leading provider of veterinary pharmacy services on behalf of the veterinarian," said Ted Root, President and CEO of VetCentric.

VetCentric's prescription management, pharmacy, and home delivery services for veterinarians improve inventory management, pet owner compliance and leads to better veterinary practice economics. VetCentric is the only national veterinary-focused pharmacy offering convenient home delivery of prescription medications and therapeutic diets to pet owners on behalf of veterinarians. By partnering with veterinarians, the VetCentric business model maintains and bolsters the veterinarian's position as the center of professional and compassionate animal care.

About VetCentric:

VetCentric, Inc. (www.vetcentric.com) is an extension of the veterinary clinic, providing an easy-to-use communication and fulfillment channel between the clinic and pet owners. Veterinarians can customize and make medication recommendations utilizing VetCentric's tools and online storefront allowing them to stay in control of treatment regimens. VetCentric improves the quality of life for companion animals by helping veterinarians deliver the right prescription products to the right place at the right time. Its innovative prescription management solutions allow veterinarians to provide better patient care, reduce costs, streamline service delivery, and improve compliance.

About Dechra:

Dechra Veterinary Products LLC, located in Overland Park, Kansas, is the U.S. subsidiary of Dechra Pharmaceuticals PLC, a UK listed company focused on international animal healthcare markets. Dechra currently markets a range of specialized veterinary products in the U.S. For more information, please visit www.dechra-us.com or call 866-933-2472.


'/>"/>
SOURCE VetCentric, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Press Ganey Unveils Physician Partnership Model
2. Partnership for Prevention: CDC Report Shows Compelling Need for FDA Regulation of Tobacco
3. Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost(R) for Image-Guided Breast Irradiation
4. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
5. ActivCore LLC Announces Strategic Partnership with Wellness in Motion
6. Nursetogether.com Partners With Tafford Uniforms
7. Gold Partners Appoints Larry Bell, M.D. President, Regulatory, Quality, Safety and Risk Management Services
8. Preferred Care Partners Management Group Deploys Voice-Assisted Care
9. The Childrens Mutual and Bounty Announce Arrival of New Child Trust Fund Partnership
10. Next Generation Ad Agency Gray & Partners Opens Headquarters in Boston
11. Stratus Technologies Partners With Infinity Healthcare Solutions to Resell Availability Products With Its Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: